In ovarian cancer, the content of the body's own thymosin-β4 was significantly lower in primary tumors and metastases than in normal tissues.
In plain wordsIn people with ovarian cancer, natural thymosin beta‑4 levels were lower in tumor tissue than in normal tissue.
- Peptide
- Thymosin beta-4 (human)
- Outcome
- DecreaseThymosin-β4 content in primary ovarian tumors and metastases versus normal tissue
- Study
n: not reported in source
ovarian cancer tissue samples- Comparator
- Normal tissue
- Outcome group
- Tumor growth · Cancer
Source sentences
In ovarian cancer significant reduction in the number of the monomer binder protein thymosin-β4 was observed in primary tumors and metastases as compared to normal tissues, but significant differences between the primary tumor and metastases were not observed.
1 context sentence(design, population, supporting numbers)
We studied the expression of actin-binding proteins and β-catenin in connection with proteasome and calpain functioning in the tissues of primary tumors and metastases of ovarian cancer.
This result measures the body's own Thymosin beta-4 (human). Nobody was given the peptide. It is not evidence about taking it.